Tags

Type your tag names separated by a space and hit enter

[The meso-caval shunt--a future standard operation?].
Chirurg. 1978 Jul; 49(7):414-8.C

Abstract

As a result of several retrospective and prospective studies, there have been remarkable changes in surgery for portal hypertension, namely the limitation of surgical interventions to an asymptomatic time interval (without bleeding), and the preference for distal shunt operations, aiming at a lasting reduction of the portal hypertension with minimal reduction of portal liver perfusion. These requirements are best met by the mesocaval (H-) shunt, using a vascular prosthesis with sufficient wall stability and a negatively charged inner surface, such as, for example, the expanded PTFE graft (Gore-TEX). In contrast to several types of splenorenal shunt, the H-shunt in mesocaval position is characterized by the following advantages: (a) minimal operative stress, even in high-risk patients, (b) technical ease of use, (c) reduced operative mortality, especially for interval operations, (d) minimal risk of recurrent bleeding and encephalopathy. From this preliminary report it may be expected that the technique of mesocaval expanded PTFE shunt here presented is likely to become the method of choice in both elective and emergency interventions.

Authors

Vollmar J
No affiliation info available
Loeprecht H
No affiliation info available
Ditschuneit H
No affiliation info available
Belohlavek D
No affiliation info available

MeSH

HumansHypertension, PortalMesenteric ArteriesMethodsPlasticsProstheses and ImplantsVena Cava, Inferior

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

679787

Citation

Vollmar, J, et al. "[The Meso-caval Shunt--a Future Standard Operation?]." Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen, vol. 49, no. 7, 1978, pp. 414-8.
Vollmar J, Loeprecht H, Ditschuneit H, et al. [The meso-caval shunt--a future standard operation?]. Chirurg. 1978;49(7):414-8.
Vollmar, J., Loeprecht, H., Ditschuneit, H., & Belohlavek, D. (1978). [The meso-caval shunt--a future standard operation?]. Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen, 49(7), 414-8.
Vollmar J, et al. [The Meso-caval Shunt--a Future Standard Operation?]. Chirurg. 1978;49(7):414-8. PubMed PMID: 679787.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [The meso-caval shunt--a future standard operation?]. AU - Vollmar,J, AU - Loeprecht,H, AU - Ditschuneit,H, AU - Belohlavek,D, PY - 1978/7/1/pubmed PY - 1978/7/1/medline PY - 1978/7/1/entrez SP - 414 EP - 8 JF - Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen JO - Chirurg VL - 49 IS - 7 N2 - As a result of several retrospective and prospective studies, there have been remarkable changes in surgery for portal hypertension, namely the limitation of surgical interventions to an asymptomatic time interval (without bleeding), and the preference for distal shunt operations, aiming at a lasting reduction of the portal hypertension with minimal reduction of portal liver perfusion. These requirements are best met by the mesocaval (H-) shunt, using a vascular prosthesis with sufficient wall stability and a negatively charged inner surface, such as, for example, the expanded PTFE graft (Gore-TEX). In contrast to several types of splenorenal shunt, the H-shunt in mesocaval position is characterized by the following advantages: (a) minimal operative stress, even in high-risk patients, (b) technical ease of use, (c) reduced operative mortality, especially for interval operations, (d) minimal risk of recurrent bleeding and encephalopathy. From this preliminary report it may be expected that the technique of mesocaval expanded PTFE shunt here presented is likely to become the method of choice in both elective and emergency interventions. SN - 0009-4722 UR - https://www.unboundmedicine.com/medline/citation/679787/[The_meso_caval_shunt__a_future_standard_operation]_ L2 - https://antibodies.cancer.gov/detail/CPTC-HLA-B-1 DB - PRIME DP - Unbound Medicine ER -